Company / Interest Expense per Share
BridgeBio Pharma, Inc. Interest Expense per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.20
FY2024
5-year range
$0.07 / $0.55
FY2020-FY2024
Trend
-36.9%
vs FY2023
Sector context
#20 of 43
Health Care
What the data says
At $0.20, BridgeBio Pharma, Inc.'s interest expense per share ranks #24 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2017 to $0.55 in FY2022.
Based on SEC 10-K filings.
0.20 in FY2024 with a 5-year CAGR of +15.5%.
Improved from $0.55 to $0.20 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +40.1%
- 5-Year CAGR
- +15.5%
- 10-Year CAGR
- -
Sector benchmark
#24 of 43 in Health CareTop 53% of 43This company $0.20 Sector average $9.80
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2024, interest expense per share decreased 36.9% year-over-year.
- Ranks #20 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2022.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.20 | -36.9% |
| FY2023 | $0.31 | -43.1% |
| FY2022 | $0.55 | +665.2% |
| FY2021 | $0.07 | -75.9% |
| FY2020 | $0.30 | +211.3% |
| FY2019 | $0.10 | +130.9% |
| FY2018 | $0.04 | +9605.8% |
| FY2017 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026